These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12531631)

  • 1. Prospects for a mucosally-administered vaccine against Helicobacter pylori.
    Svennerholm AM
    Vaccine; 2003 Jan; 21(5-6):347-53. PubMed ID: 12531631
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
    Sijun H; Yong X
    Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
    Keenan JI; Rijpkema SG; Durrani Z; Roake JA
    FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
    Chui SY; Clay TM; Lyerly HK; Morse MA
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1883-9. PubMed ID: 16103431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for therapeutic Helicobacter pylori vaccines.
    Rijpkema SGT
    J Med Microbiol; 1999 Jan; 48(1):1-3. PubMed ID: 9920118
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in vaccine development against Helicobacter pylori.
    Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
    Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
    Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against Helicobacter pylori.
    Corthésy-Theulaz I
    Recent Results Cancer Res; 2000; 156():55-9. PubMed ID: 10802863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy.
    Abadi AT
    Ann Afr Med; 2016; 15(3):154-5. PubMed ID: 27549421
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation, immunity, and vaccines for Helicobacter pylori infection.
    Velin D; Straubinger K; Gerhard M
    Helicobacter; 2016 Sep; 21 Suppl 1():26-9. PubMed ID: 27531535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity, inflammation, and vaccines for Helicobacter pylori.
    D'Elios MM; Czinn SJ
    Helicobacter; 2014 Sep; 19 Suppl 1():19-26. PubMed ID: 25167941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines.
    Stent A; Every AL; Ng GZ; Chionh YT; Ong LS; Edwards SJ; Sutton P
    Vaccine; 2012 Nov; 30(50):7214-20. PubMed ID: 23084846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new in anti-Helicobacter pylori vaccination?
    Corthesy-Theulaz I; Michetti P
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1186-90. PubMed ID: 11173731
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation, immunity, and vaccines for Helicobacter pylori infection.
    Ihan A; Pinchuk IV; Beswick EJ
    Helicobacter; 2012 Sep; 17 Suppl 1(Suppl 1):16-21. PubMed ID: 22958150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.